TacGhee Yi
Overview
Explore the profile of TacGhee Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park J, Park C, Yi T, Kim S, Iwata T, Yun J
Int J Mol Sci
. 2020 May;
21(11).
PMID: 32466616
The periodontal complex consisting of alveolar bone, cementum, and periodontal ligaments (PDL) supports human teeth through the systematic orchestration of mineralized tissues and fibrous tissues. Importantly, cementum, the outermost mineralized...
2.
Lee S, Yi T, Ahn S, Lim D, Kim S, Lee H, et al.
Anal Chim Acta
. 2018 May;
1024:112-122.
PMID: 29776537
Mesenchymal stem cells (MSCs) are a promising therapeutic option for cell-based therapy due to their immunomodulatory and regenerative properties. They can be isolated from various adult tissues, including bone marrow,...
3.
Lee H, Kim S, Jeon M, Yi T, Song S
Sci Rep
. 2017 Mar;
7:44486.
PMID: 28290526
Mesenchymal stem cells (MSCs) can modulate lymphocyte proliferation and function. One of the immunomodulatory functions of MSCs involves CD4CD25FoxP3 regulatory T cells (Tregs), which negatively regulate inflammatory responses. MSC-mediated Treg...
4.
Yoo H, Lee K, Na K, Zhang Y, Lim H, Yi T, et al.
Cell Death Dis
. 2017 Feb;
8(2):e2632.
PMID: 28230853
Mesenchymal stromal cells (MSCs) are known to suppress T-cell activation and proliferation. Several studies have reported that MSCs suppress CD25 expression in T cells. However, the molecular mechanism underlying MSC-mediated...
5.
Yi T, Lee S, Choi N, Shin H, Kim J, Lim J
Sci Rep
. 2016 Nov;
6:36303.
PMID: 27824146
A better understanding of the biology of tissue-resident stem cell populations is essential to development of therapeutic strategies for regeneration of damaged tissue. Here, we describe the isolation of glandular...
6.
Kim K, Yi T, Yun J
J Periodontol
. 2016 Feb;
87(7):e148-58.
PMID: 26889590
Background: Human periodontal ligament stem cells (hPDLSCs) are readily accessible and represent a promising source of mesenchymal stem cells (MSCs) for therapies. For expected clinical applications of stem cell therapies,...
7.
Yi T, Jun C, Kim S, Yun J
Tissue Eng Part A
. 2016 Jan;
22(5-6):501-12.
PMID: 26825430
Human periodontal ligament stem cells (hPDLSCs) are considered potential cellular carriers for gene delivery in the field of tissue regeneration. This study tested the osseoregenerative potential of hPDLSCs transduced with...
8.
Kim S, Lee H, Jeon M, Yi T, Song S
Immune Netw
. 2015 Nov;
15(5):241-51.
PMID: 26557808
Bone marrow-derived mesenchymal stem cells (MSCs) have immunomodulatory properties and can suppress exaggerated pro-inflammatory immune responses. Although the exact mechanisms remain unclear, a variety of soluble factors are known to...
9.
Shim G, Kim G, Choi J, Yi T, Cho Y, Song S, et al.
Colloids Surf B Biointerfaces
. 2015 Oct;
136:634-40.
PMID: 26479832
Here, we report a chimeric peptide-tethered fibrin hydrogel scaffold for delivery of human mesenchymal stem cells (hMSC). Osteopontin-derived peptide (OP) was used as an hMSC-tethering moiety. OP showed hMSC adhesion...
10.
Yi T, Kim S, Lee H, Kim J, Cho Y, Shin D, et al.
Tissue Eng Part C Methods
. 2015 Oct;
21(12):1251-62.
PMID: 26421757
Stem cell products derived from mesenchymal stem cells (MSCs) have been widely used in clinical trials, and a few products have been already commercialized. However, the therapeutic effects of clinical-grade...